The first domestic, super -display micro, high -precision surgical robot platform received several hundred million A round financing

The fiery surgical robot market ushered in a strong shock.

The arterial network was informed the first time that the ultra -display micro -micro -precision surgery robot platform Enterprise Aung Tai Micro -essence Medical Technology (Shanghai) Co., Ltd. (hereinafter referred to as "Ang Tai Microex") recently completed hundreds of millions of yuan A financing. This round of financing is led by Qiming Investment, which is adjacent to Xingde Venture Capital, Dongjiu Xinyi Capital, Lingang Blue Bay Fund, and Ruihua Holdings. Life Capital is the exclusive financial adviser to financing this round of financing. Financing funds will be mainly used for company product research and development, team expansion and GMP plant construction.

As the world's first robot platform that focuses on small refined surgery, and at the same time, it has successfully realized the surgical robot system without shake operation. The huge amount of funds in this time not only provided great thrust for the future development of Ang Tai Micro, but also injected vitality into the surgical robot industry and minimally invasive surgery.

Ang Tai Microex will also be continuously refined with universal micro -surgical robots, ophthalmology robots, and the core technologies of gastroscopy robot products, and explore more surgical robot application scenarios that can complete the main and slave operation. Surgical robot product pipelines, realizing the development of single technology application to technology ecology.

Is it difficult for humans to break through the physiological limit, can robots do it?

Looking back at the development of domestic surgical robots. From laparoscopic robots, orthopedic surgery robots, vascular intervention surgery robots, natural cavity surgery robots, to pescial puncture surgery robots, startups have not spent too much time to achieve innovation breakthroughs and win market recognition.

However, due to eye, blood vessels, and nerve surgery involving fine anatomical structures, under the premise of ensuring high accuracy and high stability of operations, it is performed in a narrow gap such as blood vessels, nerves, etc. It is complicated and involved in more precision components, and a higher threshold has also been set in the manufacturing and design process. The field of micro -surgical or high requirements for refinement, so the development of surgical robot systems was once fell into a bottleneck.

After all, it is necessary to meet the surgical operation requirements that have higher requirements for precision, and ultimately achieve small micro -surgical operations, precise operations, and small effects. The surgical robot system first needs to have a mechanical structure design with high rigidity, scope of motion, high motion, and high precision. Secondly, there must be stable and strong bases. Finally Realize precise positioning operations.

This level alone is enough to stuck a large number of people.

Looking at international, the field of micro -operation surgery robots is currently only developed by the Symani system developed by Italian MEDICAL Micro Instruments, and Musa system developed by the Dutch company Microsure. In the domestic micro -surgical, ophthalmology, the robot market is almost blank and rarely landed.

However, the micro -surgical robot enterprise was scarce, the track was almost blank, and Ang Tai Microex took the lead in breaking this problem. What did you do?

The underlying parts and robotic arms are self -developed and self -developed. It iterates the existing servo transmission and consumable processing technology based on the Angtai -style processing system

To break through the various problems mentioned above, R & D people must redefine the two factors of precision and minimally invasive. This is not only a must -have for micro -surgical surgery robots, but also the cornerstone of the iteration of future surgery robots. However, this technical point is often easy to be ignored and technical challenges.

At the beginning of its establishment, Ang Tai Micro -essence noticed the value of this direction. With precision and minimally invasive direction, through the accumulation of decades of research results, the core technology of the super -display micro -surgical robot was broken, and at the same time, the underlying parts of the surgical robot were realized. And the servo system, transmission, and consumable components are developed by themselves. Based on the 4 high -level capabilities, the company has the first Angtai processing system and continuously iterates existing processing technology to turn more refined and slightly possible.

The reason why companies can gain market favor is to a large extent from the company's pursuit of refined, more small, and more accurate operations, and including the core underlying technological attack, supply chain opening, product production and process optimization, etc. Clear the path.

As an investor in Angtai Microex Angel, Zhang Yibo, director of Capital Capital, told the arterial network: "The technology is implemented, and the possibility of growth. Ang Tai Micro is the first to complete the main and slave operation surgery robot in the Chinese market. Autonomously developed companies, but before we achieved this technology breakthrough, we saw the development potential of this company. Ang Tai Microex Japanese team broke the core underlying technology early and The second development and processing are very advantageous. We believe that based on the above technical capabilities, companies will have inexhaustible motivation regardless of the improvement of existing products and future innovation iterations. "

Zhang Ao, executive director of Qiming Venture Capital, said: "The design and development of ultra -micro -micro -robotic robotics is very challenging and involved many processes, but we have seen that Ang Tai's micro -essence team has done very well before. The company's independent intellectual property rights and The "Know-How" in craftsmanship can ensure that its product is leading internationally, and at the same time, the degree of freedom of IP provides the foundation for enterprises to achieve international and commercial development in the future. It will be a global story. This is also a major reason we are optimistic about this company. "As the exclusive financial adviser of this round, Sylvia Siu, the managing director of Life Capital, said:" Angtai Microex is a typical 'advanced door, After walking away, see the company with slight light ', after aiming at the blue ocean market with a very clinical value, it is down -to -earth, working hard, and doing difficult and correct things. After more than ten years of technical precipitation, Ang Tai Microex appears to everyone It is the first product that is the first to achieve breakthroughs and occupy the technical highland in the world. It is a product that can truly expand the boundaries of the surgical and give full play to the core value of the robot.

At present, the micro -surgical robot developed by Ang Tai Microex is the world's most refined surgical robot. With exquisite and long life consumables; its main and consuming operating soft tissue robots, how much freedom is, the compact volume can be quickly deployed in various operating rooms; MM blood vessels and lymphatic vessels.

The world's first focus on small refined surgical robot platforms, products covering micro -surgery, ophthalmology, gastroscopy, multiple departments

The realization of core technology is foundation. The landing of the solution is a high -rise building.

The solution provided by Ang Tai Micro can not only help doctors overcome the impact of hands trembling, but also greatly reduce the fatigue fatigue of doctors, while shortening their learning curves and further improving the accuracy and quality of surgery. Not only that, the core technology based on Ang Tai micro -essence can also iterate its surgical robot product pipeline, so that this technology covers more of the surgical robot application scenarios that requires the main and slave micro -operation, and complete the leap from a single technology application to the technology ecology. Essence

Based on the underlying core technology, the company currently mainly develops three surgical robots, namely universal micro -surgical robots, ophthalmology robots, and gastroscopy robots. Among them, GM micro -surgical robots, as well as ophthalmological surgery robots, have begun to prepare relevant types of inspection documents, and are expected to report this year. Gastroscopy robots will be reported next year.

Its universal microscopic robot can cover the entire surgical field including otolaryngology, neurosurgery, vascular surgery, plastic surgery, etc., to assist existing medical robots (such as orthopedic robots, laparoscopic robots, vascular intervention robots, etc.) to complete it to complete it. The unable to complete the technical type with higher precision.

For clinical pain points such as the limitations of the ophthalmological surgery and the accuracy of conventional robots, the ophthalmology robots independently developed by Angtai Microex have achieved micron -level single -step motion, which can fully meet the requirements of high -precision surgery in the bottom of the eye.

At the same time, noticing that the endoscopic mucosal stripping is started, the existing equipment has only three degrees of freedom, complicated operation methods, long learning curves, and improper operation. Enterprises develop gastrointestinal robots, using flexible arms less than 3mm, and more freedom clamps. The maximum of the surgical robot can be reached 180 degrees, which can achieve the smallest and most accuracy surgery in the world. While ensuring the accuracy and safety of the surgery, it effectively shortens the doctor's learning line.

In addition to the breakthrough of the core technology of the surgical robot system, Ang Taiwei believes that it is necessary to deepen the operation space in the head of the skull for surgical operations. It must rely on more fine and more dexterous surgical equipment. Therefore, the company has also independently developed related equipment for surgical robots to conduct in -depth research on soft and hardware.

The redundant human -machine combined with the design accurate and flexible design, which can match the capillaries and lymphatic vessels with a diameter of 0.3mm diameter

In the process of communicating with investors and enterprises, the artery network tried to find the reasons why Ang Tai Microex can get breakthrough in the almost blank ultra -micro micro -surgical robot market. In many clues, it can be seen that its winning points include the team's focus on technology and the correct judgment of clinical needs, and the appropriate position at the right time.

The founder of Ang Tai Microex had a deep study in the field of robotics and accumulated to Tokyo University of Technology. This experience makes him more controllable in the judgment of the most important constituent of robots and the judgment of the research and development path and direction of related mechanical products. As early as 2011, the R & D team of Angtai Microex started to develop cutting -edge technologies with Japanese and American medical giants.

According to Angtai Micro -Essence, even the medical giants in Japan and the United States still have a lot of deficiencies and improvement in the production process of mature products recognized by the market. The above -mentioned parts cooperated with the medical giants to design and develop equipment to produce and detect their existing medical products to help cooperative companies develop in the future.

Because the characteristics of mechanized intelligent operations developed by the enterprise itself are similar to the robotic system, and most of the technical path overlap, Ang Tai Microex also accumulates a large number of core technologies through this experience, and has not subsequently super -display micro -micro micro -micro Surgical robots provide support. Ang Tai Micro's entrepreneurial entrepreneurs were inspired by the famous Japanese neurosurgeons. In neurosurgery surgery, especially in the complex and narrow space of the skull nerve, due to human physiological tremor and fine operation, it is difficult for people to achieve refined operations, which is likely to cause many surgery involving precision operations to be completed, forming formed The so -called surgical restricted area. After aware of this pain point, Ang Tai Microex finally decided to implement the technology of super -display micro -surgical robotics.

After determining the direction of R & D, the founders of Ang Tai Microex gathered in Japan's top photoelectric team. In the research and development direction, there are colleges and universities such as the University of Tokyo and Tokyo University of Technology for cutting -edge technical guidance. Combined with Chinese doctors with rich clinical experience in China, Ang Tai Micro essence continues to explore the possibility of this technology through high -medical workers.

After more than ten years of technology exploration and precipitation, Ang Tai Microex cuts in from minimally invasive micro -technology, achieving a breakthrough in related technologies, becoming the world's first robot platform that focuses on small refined surgery. At the same time Company that shakes operation.

It is understood that the product is compact and can be placed in any specifications of operating rooms, wards, and even places in ambulances, space stations and other scenarios. The corresponding scenarios are very low and the setting time is short.

This can not only become a more likely possible weapon for extended operation, but also help doctors to shorten the learning curve and solve clinical pain points in multiple aspects. The driverless driving system is matched with fine and dexterous clamps, and it can even match the capillaries and lymphatic vessels with a diameter of 0.3mm diameter.

Ultra -display micro -surgical robot is a technical path that must be achieved in the future

Since the birth of surgery robots, it has been highly hoped.

Compared with open surgery and traditional minimally invasive surgery, surgery robots have overcome the shortcomings of traditional surgical wounds, long surgical time, insufficient accuracy, and prone to infection through the form of robotics. The risk of operation error reduces the risk of postoperative complications, while shortening the doctor's learning curve.

However, the development of surgical robots is a long process of clinical and market verification. Due to factors such as patent monopoly, domestic development is relatively late. At present, laparoscopic robotics, tingling surgery robots, and joint surgery robots are used in the entire market. With the breakthrough of the corresponding technology, the robotics of vascular intervention surgery have gradually developed.

However, plastic surgery, ophthalmology, pediatrics and other specialized departments that have demand for refined surgery are still mainly based on doctors for surgery. The corresponding surgical robot products are relatively scarce. At present, only two MUSA or Symani, which are developed by foreign manufacturers.

The contradiction is exactly here. On the one hand, the current visual navigation system and the development of medical imaging technology make the images seen by doctors more clearly, but on the operation side, the traditional mode of manual operation is still the mainstream. Hurry up. On the other hand, from the perspective of surgery itself, surgery involving fine anatomical structures has higher accuracy, but due to human physiological tremor and fine operation, there are limitations for human hands to perform tiny -scale operations, and the success rate of surgery is low.

In the field of surgery or high -quality operations, ultra -display micro -robots can complete the surgery that cannot be completed in the past. For existing clinical methods, it is extremely substitution. Facing areas with relatively scarce high -quality medical resources, this technology can benefit more patients due to the small area and wide adaptation. The birth of a general -purpose ultra -display micro -surgical robot can undoubtedly meet the needs of unsatisfactory clinical metals to a certain extent, and it is a technical path that must be realized in the future.

Therefore, the use of surgery robot technology to replace some people's work, narrow the impact of small movements such as hand tremor on the surgery, and expand the surgical boundary at the same time, which is not only just needed, but also very valuable.

Although mature products in this field are relatively scarce, there may be a long way to go in the future. However, as domestic manufacturers such as Ang Tai Microcellous take the first step, we can believe that after the product value is verified by the market, the super -display micro -surgical robot track will also run out of many outstanding companies. At the same time The same giant.

- END -